Please use this identifier to cite or link to this item: http://10.9.150.37:8080/dspace//handle/atmiyauni/1117
Title: Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis
Authors: Patel, Jaydeep
Dhingani, Anjali
Garala, Kevin
Raval, Mihir
Sheth, Navin
Keywords: Bioavailability
Nanosuspension
Nanocrystals
Principal component analysis
Quality by design
Telmisartan
Issue Date: Mar-2014
Publisher: Powder Technology, Elsevier
Citation: Patel, J. ,Dhingani, A. ,Garala, K. ,Raval, M. ,Sheth, N. (2014). Design and development of solid nanoparticulate dosage forms of telmisartan for bioavailability enhancement by integration of experimental design and principal component analysis. Powder Technology, Elsevier. 258 (2014) 331–34, ISSN : 0032-5910. http://dx.doi.org/10.1016/j.powtec.2014.03.001
Abstract: Aim of the present investigation was to develop nanoparticulate solid oral dosage forms of a poorly water soluble antihypertensive agent, telmisartan (TLM) by converting the optimized batch of drug loaded nanosuspensions into a tablet dosage form using lyophilization technique. The TLM loaded nanosuspensions were optimized by implementation of 32 full factorial design along with principal component analysis (PCA) with concentration of stabilizer and amount of milling agents as factors. The optimized batch of TLM loaded nanosuspension exhibited a mean particle size of 334.67 ± 10.43 nm. The results of various instrumental techniques illustrated retention of drug crystallinity after milling and lyophilization. The results of in vitro drug release study of tablets containing drug nanocrystals revealed remarkable improvement in the dissolution rate as compared to the marketed tablet (Sartel® 20). The results of in vivo pharmacokinetic study on Wister rats revealed 1.5-fold enhancement in oral bioavailability for tablets containing TLM nanocrystals against the marketed tablets. The present study proposed nanosuspension as a suitable approach for developing nanosized solid oral dosage forms of poorly water soluble drugs like telmisartan using design of experiment and principal component analysis as two important paradigms of quality by design technique.
URI: http://10.9.150.37:8080/dspace//handle/atmiyauni/1117
ISSN: 0032-5910
Appears in Collections:01. Journal Articles

Files in This Item:
File Description SizeFormat 
981) 23661_Kevin Chandulal Garala.pdf540.03 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.